avalere health limited

Live MatureMidHealthy

avalere health limited Company Information

Share AVALERE HEALTH LIMITED

Company Number

04269638

Shareholders

fishawack medical communications limited

Group Structure

View All

Industry

Other human health activities

 

Registered Address

the featherstone building, 66 city road, london, EC1Y 2AL

avalere health limited Estimated Valuation

£5.9m

Pomanda estimates the enterprise value of AVALERE HEALTH LIMITED at £5.9m based on a Turnover of £8.9m and 0.66x industry multiple (adjusted for size and gross margin).

avalere health limited Estimated Valuation

£15.6m

Pomanda estimates the enterprise value of AVALERE HEALTH LIMITED at £15.6m based on an EBITDA of £3.1m and a 5.08x industry multiple (adjusted for size and gross margin).

avalere health limited Estimated Valuation

£49.1m

Pomanda estimates the enterprise value of AVALERE HEALTH LIMITED at £49.1m based on Net Assets of £20.9m and 2.35x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Avalere Health Limited Overview

Avalere Health Limited is a live company located in london, EC1Y 2AL with a Companies House number of 04269638. It operates in the other human health activities sector, SIC Code 86900. Founded in August 2001, it's largest shareholder is fishawack medical communications limited with a 100% stake. Avalere Health Limited is a mature, mid sized company, Pomanda has estimated its turnover at £8.9m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Avalere Health Limited Health Check

Pomanda's financial health check has awarded Avalere Health Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

6 Strong

positive_score

2 Regular

positive_score

3 Weak

size

Size

annual sales of £8.9m, make it larger than the average company (£725k)

£8.9m - Avalere Health Limited

£725k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (7.2%)

9% - Avalere Health Limited

7.2% - Industry AVG

production

Production

with a gross margin of 45.6%, this company has a comparable cost of product (38.6%)

45.6% - Avalere Health Limited

38.6% - Industry AVG

profitability

Profitability

an operating margin of 34.3% make it more profitable than the average company (5.1%)

34.3% - Avalere Health Limited

5.1% - Industry AVG

employees

Employees

with 115 employees, this is above the industry average (18)

115 - Avalere Health Limited

18 - Industry AVG

paystructure

Pay Structure

on an average salary of £26.4k, the company has an equivalent pay structure (£26.4k)

£26.4k - Avalere Health Limited

£26.4k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £77.6k, this is more efficient (£45.6k)

£77.6k - Avalere Health Limited

£45.6k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 61 days, this is later than average (20 days)

61 days - Avalere Health Limited

20 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 2 days, this is quicker than average (18 days)

2 days - Avalere Health Limited

18 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Avalere Health Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 6 weeks, this is less cash available to meet short term requirements (126 weeks)

6 weeks - Avalere Health Limited

126 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 7.2%, this is a lower level of debt than the average (22.4%)

7.2% - Avalere Health Limited

22.4% - Industry AVG

AVALERE HEALTH LIMITED financials

EXPORTms excel logo

Avalere Health Limited's latest turnover from March 2024 is £8.9 million and the company has net assets of £20.9 million. According to their latest financial statements, we estimate that Avalere Health Limited has 115 employees and maintains cash reserves of £217.7 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Nov 2013Nov 2012Nov 2011Nov 2010Nov 2009
Turnover8,925,4837,166,8316,842,5066,834,1984,059,5383,953,6334,009,4524,692,8644,860,4165,233,6895,917,78310,113,9787,969,3754,789,098
Other Income Or Grants
Cost Of Sales4,859,0835,034,5564,113,0183,557,5412,264,1062,243,4672,294,7952,998,9443,544,5494,177,5803,698,2347,358,7325,730,8653,430,285
Gross Profit4,066,4002,132,2752,729,4883,276,6571,795,4321,710,1661,714,6571,693,9201,315,8671,056,1092,219,5492,755,2452,238,5101,358,813
Admin Expenses1,004,240204,422259,500789,252403,216556,132515,746-284,613480,557563,5141,323,4362,367,8171,984,2401,229,368-226,634
Operating Profit3,062,1601,927,8532,469,9882,487,4051,392,2161,154,0341,198,9111,978,533835,310492,595896,113387,428254,270129,445226,634
Interest Payable23,18011,49613,3537,9109,6626,53191,866
Interest Receivable1,904,155849,151418,471264,8351239,2862,2232,2712,147820
Pre-Tax Profit4,943,1352,765,5082,875,1062,744,3301,392,2161,144,3721,198,9111,978,656835,310486,064813,533389,651256,541131,592227,454
Tax229280,553-278,39567,830191,369-218,174357,805-438,25914,345-54,028-232,939-93,516-66,701-36,846-63,687
Profit After Tax4,943,3643,046,0612,596,7112,812,1601,583,585926,1981,556,7161,540,397849,655432,036580,594296,135189,84094,746163,767
Dividends Paid411,395
Retained Profit4,943,3643,046,0612,596,7112,812,1601,583,585514,8031,556,7161,540,397849,655432,036580,594296,135189,84094,746163,767
Employee Costs3,041,4742,332,6482,247,7362,270,3201,338,449111,309193,306341,772734,556616,892971,8123,197,3292,581,6221,459,600
Number Of Employees11593949859591613142015012271
EBITDA*3,064,9201,932,9482,482,0862,499,6161,402,0131,155,7151,218,4781,998,908860,410535,535950,476456,241319,761187,669294,250

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Nov 2013Nov 2012Nov 2011Nov 2010Nov 2009
Tangible Assets10,96913,72918,82430,92243,1336062,28719,81238,09558,59689,551132,076188,030208,015262,956
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets10,96913,72918,82430,92243,1336062,28719,81238,09558,59689,551132,076188,030208,015262,956
Stock & work in progress
Trade Debtors1,503,8111,313,856745,9071,295,0221,169,244497,810282,0731,240,5081,131,293955,450805,3061,422,6121,175,253733,736650,331
Group Debtors18,951,06715,417,98213,201,5999,277,3516,668,0495,046,0524,983,6013,222,4111,562,451800,629
Misc Debtors1,839,9111,320,8991,232,2171,267,3081,033,816811,710768,4181,157,926795,803381,000834,882
Cash217,7481,133,335636,278363,989152,4141,130,874398,307440,585800,053528,159432,661511,746377,494530,729328,012
misc current assets
total current assets22,512,53719,186,07215,816,00112,203,6709,023,5237,486,4466,432,3996,061,4304,289,6002,665,2382,072,8491,934,3581,552,7471,264,465978,343
total assets22,523,50619,199,80115,834,82512,234,5929,066,6567,487,0526,434,6866,081,2424,327,6952,723,8342,162,4002,066,4341,740,7771,472,4801,241,299
Bank overdraft
Bank loan
Trade Creditors 34,97233,03551,05328,29638,591208,137152,334113,154150,03775,533299,3601,177,9431,004,421825,964670,515
Group/Directors Accounts2,691,4552,084,8351,480,864718,407582,081602,843415,80844,97721,473
other short term finances
hp & lease commitments
other current liabilities1,588,287518,428788,115411,321807,707778,468305,6201,735,1071,855,9051,197,089723,955
total current liabilities1,623,2593,242,9182,924,0031,920,4811,564,7051,568,6861,060,7972,264,0692,050,9191,294,0951,023,3151,177,9431,004,421825,964670,515
loans144,000
hp & lease commitments
Accruals and Deferred Income
other liabilities144,000288,000388,000388,000
provisions2,61819,014
total long term liabilities2,618144,000144,000288,000388,000407,014
total liabilities1,623,2593,242,9182,924,0031,920,4811,564,7051,568,6861,060,7972,264,0692,050,9191,296,7131,167,3151,321,9431,292,4211,213,9641,077,529
net assets20,900,24715,956,88312,910,82210,314,1117,501,9515,918,3665,373,8893,817,1732,276,7761,427,121995,085744,491448,356258,516163,770
total shareholders funds20,900,24715,956,88312,910,82210,314,1117,501,9515,918,3665,373,8893,817,1732,276,7761,427,121995,085744,491448,356258,516163,770
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Nov 2013Nov 2012Nov 2011Nov 2010Nov 2009
Operating Activities
Operating Profit3,062,1601,927,8532,469,9882,487,4051,392,2161,154,0341,198,9111,978,533835,310492,595896,113387,428254,270129,445226,634
Depreciation2,7605,09512,09812,2119,7971,68119,56720,37525,10042,94054,36368,81365,49158,22467,616
Amortisation
Tax229280,553-278,39567,830191,369-218,174357,805-438,25914,345-54,028-232,939-93,516-66,701-36,846-63,687
Stock
Debtors4,242,0522,873,0143,340,0422,968,5722,515,537321,480413,2472,131,2981,352,4682,137,079217,576247,359441,51783,405650,331
Creditors1,937-18,01822,757-10,295-169,54655,80339,180-36,88374,50475,533-878,583173,522178,457155,449670,515
Accruals and Deferred Income1,069,859-269,687376,794-396,38629,239472,848-1,429,487-120,798658,8161,197,089723,955
Deferred Taxes & Provisions-2,6182,618-19,01419,014
Cash flow from operations-105,107-947,218-736,800-807,807-1,062,4621,144,712-227,271-728,330252,989-380,332345,333288,888-10,000203,853269,761
Investing Activities
capital expenditure-52,324-2,042-2,092-4,599-101,536-11,838-12,859-45,506-3,283-330,572
Change in Investments
cash flow from investments-52,324-2,042-2,092-4,599-101,536-11,838-12,859-45,506-3,283-330,572
Financing Activities
Bank loans
Group/Directors Accounts-2,691,455606,620603,971762,457136,326-20,762187,035370,83123,50421,473
Other Short Term Loans
Long term loans144,000
Hire Purchase and Lease Commitments
other long term liabilities-144,000-144,000-100,000388,000
share issue29,674995,085-330,0003
interest1,880,975837,655405,118256,925-9,662123-6,531-82,5802,2232,2712,147820
cash flow from financing-810,4801,444,2751,009,0891,019,382136,326-750187,035370,95423,5041,010,027-412,580-141,777-97,7292,147388,823
cash and cash equivalents
cash-915,587497,057272,289211,575-978,460732,567-42,278-359,468271,894528,159-79,085134,252-153,235202,717328,012
overdraft
change in cash-915,587497,057272,289211,575-978,460732,567-42,278-359,468271,894528,159-79,085134,252-153,235202,717328,012

avalere health limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for avalere health limited. Get real-time insights into avalere health limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Avalere Health Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for avalere health limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in EC1Y area or any other competitors across 12 key performance metrics.

avalere health limited Ownership

AVALERE HEALTH LIMITED group structure

Avalere Health Limited has no subsidiary companies.

Ultimate parent company

2 parents

AVALERE HEALTH LIMITED

04269638

AVALERE HEALTH LIMITED Shareholders

fishawack medical communications limited 100%

avalere health limited directors

Avalere Health Limited currently has 6 directors. The longest serving directors include Mrs Gail Flockhart (Nov 2021) and Mr Jonathan Koch (Nov 2021).

officercountryagestartendrole
Mrs Gail FlockhartUnited Kingdom60 years Nov 2021- Director
Mr Jonathan KochUnited Kingdom50 years Nov 2021- Director
Mr Brendan FerrettiEngland45 years Jun 2022- Director
Mr John GranseeUnited Kingdom59 years Jan 2024- Director
Mrs Harriet ShurvilleUnited Kingdom38 years Jan 2025- Director
Amar UrhekarUnited Kingdom50 years Jan 2025- Director

P&L

March 2024

turnover

8.9m

+25%

operating profit

3.1m

+59%

gross margin

45.6%

+53.13%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

20.9m

+0.31%

total assets

22.5m

+0.17%

cash

217.7k

-0.81%

net assets

Total assets minus all liabilities

avalere health limited company details

company number

04269638

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

August 2001

age

24

incorporated

UK

ultimate parent company

accounts

Audit Exemption Subsidiary

last accounts submitted

March 2024

previous names

fishawack facilitate limited (August 2024)

facilitate limited (July 2014)

accountant

-

auditor

-

address

the featherstone building, 66 city road, london, EC1Y 2AL

Bank

-

Legal Advisor

-

avalere health limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 5 charges/mortgages relating to avalere health limited. Currently there are 0 open charges and 5 have been satisfied in the past.

avalere health limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for AVALERE HEALTH LIMITED. This can take several minutes, an email will notify you when this has completed.

avalere health limited Companies House Filings - See Documents

datedescriptionview/download